EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differentiation of Human Glioblastoma Stem Cells as a Prospective Tool to Find New Biomarkers and Molecular Targets: A Proteomic and Lipidomic Approach

Ana M Cardoso, Diana Serra iD, Cristina P R Xavier iD, João P Monteiro iD, Catarina M Morais iD, Isabel M Nunes Correia, Maria do Rosário M Domingues iD, M Helena Vasconcelos iD, Amália S Jurado, Maria C Pedroso de Lima iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219517 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Ana M Cardoso und 9 weiteren Autor:innen. Beteiligte Einrichtung: CIBB-Centre for Innovative Biomedicine and Biotechnology, CNC-UC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, P…. Hauptthemen laut MEDLINE: Glioblastoma, Neoplastic Stem Cells, Cell Differentiation, Proteomics. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology, EU Recovery and Resilience Facility and Portuguese national funds, FCT—Fundação para a Ciência e a Tecnologia I.P..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although glioblastoma stem cells (GSCs) constitute a small subpopulation of this highly heterogeneous brain cancer, they are widely recognised as key drivers of tumour recurrence after surgical resection and resistance to radiotherapy and chemotherapy. Differentiation of GSCs has, therefore, emerged as a strategy to increase glioblastoma susceptibility to therapeutic and surgical interventions. Cellular and molecular heterogeneity of glioblastoma limits the effectiveness of any treatment that relies on single molecules identified as disease-specific biomarkers. In this context, lipidomic and proteomic profiles constitute a source of information that can be translated into the identification of clinically relevant diagnostic and prognostic biomarkers, and novel therapeutic targets towards eradication of this lethal disease. Our initial studies demonstrated that BMP4 induced differentiation of the human glioblastoma stem cells G144 with approximately a 30-fold increase in expression of the astrocytic marker GFAP, which was coupled with a reduction in cell proliferation (33% decrease in EDU incorporation), invasion (61% decrease) and tumoursphere growth (53% decrease in area), and enhanced senescence-associated β-galactosidase activity (5.9-fold increase). Lipidomic and proteomic analysis (using data from 3 and 4 independent experiments, respectively) was then performed, allowing the identification of specific lipids and proteins exclusively detected or predominant in stem or differentiated G 144 cells. Importantly, our findings, which revealed a 6-fold increase in GFAP expression upon downregulation of a specific protein detected only in stem cells (SPRY4), pave the way for the employment of the RNAi-mediated knockdown strategy as a mechanistically distinct alternative to the use of BMP4, and highlight this protein as a candidate regulator associated with the G144 stem-like phenotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeoplastic Stem CellsCell DifferentiationProteomicsBiomarkers, TumorLipidomicsBrain NeoplasmsHumansBone Morphogenetic Protein 4Cell Line, TumorCell ProliferationGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

BMP4-induced differentiationG144 glioblastoma stem cellsSPRY4 (sprouty RTK signalling antagonist 4) proteincell proliferationether lipidsinvasionliquid chromatography–mass spectrometry (LC–MS/MS)senescencesiRNA-mediated gene silencingtumour sphere formation

Substanzen

Biomarkers, TumorBone Morphogenetic Protein 4BMP4 protein, humanGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • CIBB-Centre for Innovative Biomedicine and Biotechnology, CNC-UC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal.
  • CIVG-Vasco da Gama Research Center, EUVG-Vasco da Gama University School, 3020-210 Coimbra, Portugal.
  • i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.
  • Associate Laboratory i4HB, Institute for Health and Bioeconomy, University Institute of Health Sciences-CESPU, 4585-116 Gandra, Portugal.
  • UCIBIO-Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal.
  • Centro de Espetrometria de Massa & LAQV-REQUIMTE & Departamento de Química, Universidade de Aveiro, Campus Universitário de Santiago, 3810-193 Aveiro, Portugal.

ORCID-Profile: Diana Serra, Cristina P R Xavier, João P Monteiro, Catarina M Morais, Maria do Rosário M Domingues, M Helena Vasconcelos, Maria C Pedroso de Lima

Förderung

  • Foundation for Science and Technology
  • EU Recovery and Resilience Facility and Portuguese national funds
  • FCT—Fundação para a Ciência e a Tecnologia I.P.
  • Portuguese Mass Spectrometry Network

Zitieren

APA

Cardoso, A. M., Serra, D., Xavier, C. P. R., Monteiro, J. P., Morais, C. M., Correia, I. M. N., Domingues, M. D. R. M., Vasconcelos, M. H., Jurado, A. S., & Lima, M. C. P. (2026). Differentiation of Human Glioblastoma Stem Cells as a Prospective Tool to Find New Biomarkers and Molecular Targets: A Proteomic and Lipidomic Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219517

Vancouver

Cardoso AM, Serra D, Xavier CPR, Monteiro JP, Morais CM, Correia IMN, et al. Differentiation of Human Glioblastoma Stem Cells as a Prospective Tool to Find New Biomarkers and Molecular Targets: A Proteomic and Lipidomic Approach. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219517

BibTeX
@article{Cardoso2026,
  author = {Cardoso, Ana M and Serra, Diana and Xavier, Cristina P R and Monteiro, João P and Morais, Catarina M and Correia, Isabel M Nunes and Domingues, Maria do Rosário M and Vasconcelos, M Helena and Jurado, Amália S and Lima, Maria C Pedroso de},
  title = {Differentiation of Human Glioblastoma Stem Cells as a Prospective Tool to Find New Biomarkers and Molecular Targets: A Proteomic and Lipidomic Approach},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219517}
}
Kostenlos starten →